ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "socioeconomic factors"

  • Abstract Number: 0616 • ACR Convergence 2024

    Disparities in Health-Related Quality of Life Among Patients with Systemic Lupus Erythematosus

    Victoria Delk1, Dulaney Wilson2, Gary Gilkeson2, Jim Oates2 and Diane Kamen2, 1Medical University of South Carolina, North Charleston, SC, 2Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with the potential to severely diminish patients' quality of life (QoL). SLE disproportionately affects young…
  • Abstract Number: 1673 • ACR Convergence 2024

    Assessing the Feasibility of a Mediterranean-Style Diet for Patients with Rheumatoid Arthritis in a Racially and Culturally Diverse Population Across the United States

    Chelsea Thompson1, iazsmin Ventura1, Cuoghi Edens2, Tamiko Katsumoto3 and Sowmya Popuri4, 1Section of Rheumatology, University of Chicago, Chicago, IL, 2Section of Pediatric Rheumatology, Section of Rheumatology, University of Chicago, Chicago, IL, 3Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA, 4Section of Internal Medicine, Loyola Medicine MacNeal, Maywood, IL

    Background/Purpose: In 2023, the American College of Rheumatology published a conditional recommendation for patients living with Rheumatoid Arthritis to follow a “Mediterranean style” diet. However,…
  • Abstract Number: 2592 • ACR Convergence 2024

    The Effects of Early Life Trauma and Socioeconomic Position on Systemic Lupus Erythematosus Risk in Adulthood

    Jennifer Woo1 and Dale Sandler2, 1Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, 2Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC

    Background/Purpose: Early life trauma (ELT) and neighborhood deprivation (ND)—a measure of socioeconomic position (SEP)—represent two aspects of the early life social environment that can be…
  • Abstract Number: 0668 • ACR Convergence 2024

    There Are No Shortcuts: Electronic Health Record-Generated Tool Does Not Reflect Medication Adherence in Patients with SLEin Bronx, NY

    Kiera Brennan1, Kai Sun2, Anitha Ramu1, Juliann Allen1, Justina Shafik1 and Noa Schwartz3, 1Albert Einstein College of Medicine, Bronx, NY, 2Duke University, Durham, NC, 3Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Nonadherence to hydroxychloroquine (HCQ) is associated with poor outcomes in SLE.1 Electronic Health Record (EHR) platforms collect data on patient medication access through dispensing…
  • Abstract Number: 1746 • ACR Convergence 2024

    Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Rheumatoid Arthritis

    Andreas Kerschbaumer1, Marlene Steiner2, Pascale Pruckner1, Josef Smolen3 and Daniel Aletaha4, 1Medical University of Vienna, Vienna, Wien, Austria, 2Medical University Vienna, Vienna, Wien, Austria, 3Medical University of Vienna, Vienna, Austria, 4Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Wien, Austria

    Background/Purpose: Therapeutic advances of the recent past have led to significant changes in clinical practice when treating patients with rheumatoid arthritis (RA). Since the advent…
  • Abstract Number: 2681 • ACR Convergence 2024

    Association of Social Determinants of Health with Systemic Lupus Erythematosus in the United States: Nationally Representative Estimates for 2017-2021

    Ami Vyas, Steven Cohen and Christine Eisenhower, University of Rhode Island, Kingston, RI

    Background/Purpose: Careful assessment of individuals’ social determinants of health (SDOH) that affect systemic lupus erythematosus (SLE) is crucial, as such evidence will improve care and…
  • Abstract Number: 0723 • ACR Convergence 2024

    Sociodemographic Factors Associated with Clinic Non-attendance and Unscheduled Emergency Care Episodes in ANCA-associated Vasculitis

    Warren RG James1, Corri Black1, Neil Basu2, Mark A Little3 and Rosemary Hollick1, 1University of Aberdeen, Aberdeen, United Kingdom, 2University of Glasgow, Glasgow, Scotland, United Kingdom, 3Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Increasing evidence suggests that socioeconomic status drives differences in outcomes for people with rheumatic conditions. Individuals with complex, rare rheumatic conditions such as antineutrophil…
  • Abstract Number: 1873 • ACR Convergence 2024

    Race/Ethnicity and Household Income at the County Level Interacts with the Association of Urbanicity and Lupus Nephritis Mortality

    Snehin Rajkumar1, Eric Yen2 and Ram Singh3, 1UCLA David Geffen School of Medicine, Irvine, CA, 2UCLA, Los Angeles, CA, 3UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: The reasons underlying substantial variation in lupus nephritis (LN) deaths by race/ethnicity remain largely unknown. There are no large population-based studies focused on the…
  • Abstract Number: 0772 • ACR Convergence 2024

    Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Psoriatic Arthritis

    Andreas Kerschbaumer1, Marlene Steiner2, Suzanne D. Khalili1, Daniel Aletaha3 and Josef Smolen4, 1Medical University of Vienna, Vienna, Wien, Austria, 2Medical University Vienna, Vienna, Wien, Austria, 3Department of Medicine III, Division of Rheumatology, Medical University of Vienna, Wien, Austria, 4Medical University of Vienna, Vienna, Austria

    Background/Purpose: Therapeutic advances of the recent past have led to significant changes in clinical practice when treating patients with psoriatic arthritis (PsA). Since the advent…
  • Abstract Number: 1876 • ACR Convergence 2024

    Automated Case Identification of Patients with End-Stage Renal Disease and Systemic Lupus Erythematosus Using Machine Learning

    Mario Felix1 and Lais Osmani2, 1Yale, Hamden, CT, 2Yale, New Haven, CT

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease, with 4-28% of patients developing End-Stage Renal Disease (ESRD). Accurate identification of these patients is…
  • Abstract Number: 0986 • ACR Convergence 2024

    State-and-County-Level Social Vulnerability Index and Trends in Systemic Lupus Erythematosus-Related Mortality in the U.S

    Omer Pamuk1, Ansaam Daoud2, Hasan Cetin3 and Marina Magrey4, 1University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH, 2Case Western Reserve University/University Hospitals, Akron, OH, 3Cleveland Clinic Cole Eye Institute, Cleveland, OH, 4Case Western Reserve University School of Medicine/University Hospitals, Richfield, OH

    Background/Purpose: Epidemiological studies have shown significant health disparities in systemic lupus erythematosus (SLE). The Centers for Disease Control and Prevention (CDC) developed the social vulnerability…
  • Abstract Number: 1911 • ACR Convergence 2024

    Improving Healthcare Access in Underserved Brooklyn Communities: A Comprehensive Multispecialty Patient Navigator Program

    Meenakshi Kurup1, Grace Shadid2, Jasmine Pak2, Alejandra Moncayo3, Naureen Kabani4, Soodeh Kabir5, Sharon Glick5 and Ellen Ginzler6, 1SUNY Downstate Health Sciences University, Department of Medicine, Brooklyn, NY, 2SUNY Downstate College of Medicine, Brooklyn, NY, 3SUNY Downstate Health Sciences University, College of Medicine, Brooklyn, NY, 4SUNY Downstate Medical Center, Brooklyn, NY, 5SUNY Downstate Health Sciences University, Department of Dermatology, Brooklyn, NY, 6SUNY Downstate Health Sciences University, New York, NY

    Background/Purpose: Underserved communities in the USA face significant healthcare disparities, leading to poorer clinical outcomes and higher rates of chronic diseases. Socioeconomic barriers such as…
  • Abstract Number: 0997 • ACR Convergence 2024

    Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus

    Zoe Reed1, Janis Campbell2, Xana Howard1, Teresa Aberle1, Bridget Parrish1, Wade DeJager3, Cristina Arriens1, Joan Merrill4 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, 4Oklahoma Medical Research Foundation, Oklahoma City 73104, OK

    Background/Purpose: Systemic lupus erythematosus (SLE) has a complex etiology with genetic predispositions interacting with environmental factors. Extensive environmental exposure information is now publicly available based…
  • Abstract Number: 1918 • ACR Convergence 2024

    Exploring the Childhood Opportunity Index and Distance to Care in a Cohort of Children with Rheumatic Disease

    Kristina Ciaglia1 and Alaina Beauchamp2, 1UT Southwestern Medical Center and Scottish Rite for Children, Dallas, TX, 2UT Southwestern Medical Center, Dallas

    Background/Purpose: Children from disadvantaged neighborhoods and socioeconomic backgrounds experience worse outcomes and delays in care.¹ The Childhood Opportunity Index (COI) is a multidimensional validated tool…
  • Abstract Number: 1010 • ACR Convergence 2024

    Total Cost Risk Scores and Barrier Categories in Patients with Axial Spondyloarthritis and Associated Factors

    Marina Magrey1, Yashashvi Raghuwanshi2, Tyler Barnett2, lindsay Frumker3 and Omer Pamuk4, 1Case Western Reserve University School of Medicine/University Hospitals, Richfield, OH, 2University hospitals, Cleveland, OH, 3University Hospitals Cleveland, cleveland, OH, 4University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH

    Background/Purpose: Axial spondyloarthritis (axSpA) is associated with an increased risk of morbidity and mortality. Patients with axSpA suffer from chronic back pain, and epidemiological studies…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology